Occurrence and mechanisms of glycopeptide resistance in gram-positive cocci

V Saha1, S Gupta, R S Daum

  • 1Section of Pediatric Infectious Diseases, Wyler Children's Hospital, University of Chicago, Illinois 60637.

Infectious Agents and Disease
|December 1, 1992
PubMed

Insights

Glycopeptide resistance in enterococci and staphylococci is a growing concern. Understanding the mechanisms of resistance is crucial for effective treatment strategies against these Gram-positive bacteria.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Glycopeptides were once thought to be immune to resistance development due to their unique mechanism of action.
  • However, clinical isolates of enterococci and staphylococci exhibiting resistance to glycopeptides have emerged.
  • This necessitates a re-evaluation of susceptibility assumptions for these critical pathogens.

Purpose of the Study:

  • To investigate and describe the mechanisms of glycopeptide resistance in clinically significant enterococci and staphylococci.
  • To highlight the diversity of resistance types within enterococcal species.
  • To characterize novel resistance mechanisms observed in staphylococci.

Main Methods:

  • Characterization of enzymatic activities (ligase, dehydrogenase, carboxypeptidase) involved in peptidoglycan precursor synthesis.
  • Induction studies to assess the role of enzymes in resistance.
  • Genetic analysis to identify chromosomal or inducible resistance determinants.
  • Proteomic analysis to identify novel proteins associated with resistance.
  • Laboratory-induced resistance studies in staphylococci.

Main Results:

  • Enterococci exhibit at least three distinct resistance types (A, B, and C) mediated by altered enzyme activity or novel protein production.
  • Type A resistance involves inducible enzymes affecting peptidoglycan precursors.
  • Type C resistance in E. gallinarum is linked to a constitutively produced, chromosomally encoded ligase.
  • Staphylococcal resistance mechanisms, including a 39-kDa protein and cell surface reorganization, are still under investigation.

Conclusions:

  • The era of presumed universal Gram-positive susceptibility to glycopeptides is over.
  • Distinct molecular mechanisms underlie glycopeptide resistance in enterococci and staphylococci.
  • Routine susceptibility testing is now essential for clinical isolates of enterococci and staphylococci.

Related Concept Videos

Bacterial Cell Wall01:22

Bacterial Cell Wall

The bacterial cell wall is an essential structural component that encases the plasma membrane, preserving cellular integrity, determining shape, and protecting against osmotic stress. This rigid yet flexible structure primarily comprises peptidoglycan, a polymer that forms a mesh-like matrix conferring mechanical strength and flexibility.Peptidoglycan Composition and StructurePeptidoglycan, the core of the bacterial cell wall, comprises alternating units of N-acetylglucosamine (NAG) and...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...